Xylem Inc Stock Target Price
| XYL Stock | USD 138.46 1.51 1.10% |
Fundamental analysis of Xylem allows traders to better anticipate movements in Xylem's stock price by examining its financial health and performance throughout various phases of its business cycle.
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools. Xylem Target Price Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Xylem's direct or indirect competition against its Target Price to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Xylem could also be used in its relative valuation, which is a method of valuing Xylem by comparing valuation metrics of similar companies.Xylem is currently under evaluation in target price category among its peers.
Xylem Fundamentals
| Return On Equity | 0.0856 | ||||
| Return On Asset | 0.048 | ||||
| Profit Margin | 0.11 % | ||||
| Operating Margin | 0.16 % | ||||
| Current Valuation | 34.74 B | ||||
| Shares Outstanding | 243.47 M | ||||
| Shares Owned By Insiders | 0.20 % | ||||
| Shares Owned By Institutions | 95.86 % | ||||
| Number Of Shares Shorted | 3.19 M | ||||
| Price To Earning | 64.49 X | ||||
| Price To Book | 3.02 X | ||||
| Price To Sales | 3.79 X | ||||
| Revenue | 8.56 B | ||||
| Gross Profit | 3.4 B | ||||
| EBITDA | 1.69 B | ||||
| Net Income | 890 M | ||||
| Cash And Equivalents | 1.12 B | ||||
| Cash Per Share | 6.58 X | ||||
| Total Debt | 2.12 B | ||||
| Debt To Equity | 0.75 % | ||||
| Current Ratio | 1.65 X | ||||
| Book Value Per Share | 46.02 X | ||||
| Cash Flow From Operations | 1.26 B | ||||
| Short Ratio | 2.63 X | ||||
| Earnings Per Share | 3.88 X | ||||
| Price To Earnings To Growth | 2.46 X | ||||
| Target Price | 168.06 | ||||
| Number Of Employees | 23 K | ||||
| Beta | 1.17 | ||||
| Market Capitalization | 33.68 B | ||||
| Total Asset | 16.49 B | ||||
| Retained Earnings | 3.14 B | ||||
| Working Capital | 1.76 B | ||||
| Current Asset | 2 B | ||||
| Current Liabilities | 823 M | ||||
| Annual Yield | 0.01 % | ||||
| Five Year Return | 1.15 % | ||||
| Net Asset | 16.49 B | ||||
| Last Dividend Paid | 1.56 |
About Xylem Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Xylem Inc's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Xylem using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Xylem Inc based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Prophet is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ProphetCheck out Xylem Piotroski F Score and Xylem Altman Z Score analysis. You can also try the Money Managers module to screen money managers from public funds and ETFs managed around the world.
Is Industrial Machinery & Supplies & Components space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Xylem. If investors know Xylem will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Xylem listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Xylem Inc is measured differently than its book value, which is the value of Xylem that is recorded on the company's balance sheet. Investors also form their own opinion of Xylem's value that differs from its market value or its book value, called intrinsic value, which is Xylem's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Xylem's market value can be influenced by many factors that don't directly affect Xylem's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Xylem's value and its price as these two are different measures arrived at by different means. Investors typically determine if Xylem is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Xylem's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.